Perspectives in Surgical Infections: What Does the Future Hold?

Altemeier WA . Sepsis in surgery. Presidential Address, Surgical Infection Society. Arch Surg, 1982; 117:107–112.

Wilson MA . Skin and soft tissue infections: Impact of resistant gram-positive bacteria. Am J Surg, 2003; 186:35S–41S.

Mangram AJ , Horan TC , Pearson ML et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol, 1999; 20:250–278.

Klevens RM , Edward JR et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep, 2007; 122:160–166.

Gaynes RP . Surgical-site infections and the NNIS SSI Risk Index: Room for improvement. Infect Control Hosp Epidemiol, 2000; 21:184–185.

Gaynes RP . Surgical-site infections and the NNIS Basic SSI Risk Index: Room for improvement II. Infect Control Hosp Epidemiol, 2001; 22:266–267.

Gaynes RP , Culver DH , Horan TC et al. Surgical site infection (SSI) rates in the United States, 1992–1998: The National Nosocomial Infections Surveillance System Basic SSI Risk Index. Clin Infect Dis, 2001; 33,Suppl 2:S69–S77.

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992–June 2001, issued August 2001. Am J Infect Control, 2001; 29:404–421.

Campbell DA Jr , Henderson WG , Englesbe MJ et al. Surgical site infection prevention: The importance of operative duration and blood transfusion, results of the first American College of Surgeons National Surgical Quality Improvement Program Best Practices Initiative. J Am Coll Surg, 2008; 207:810–820.

Malone DL , Genuit T , Tracy JK et al. Surgical site infections: Reanalysis of risk factors. J Surg Res, 2002; 103:89–95.

Mangram AJ , Horan TC , Pearson ML et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol, 1999; 20:250–278.

Bratzler DW , Houck PM , Richards C et al. Use of antimicrobial prophylaxis for major surgery: Baseline results from the National Surgical Infection Prevention Project. Arch Surg, 2005; 140:174–182.

Taylor M , Napolitano L . Methicillin-resistant Staphylococcus aureus infections in vascular surgery: Increasing prevalence. Surg Infect, 2004; 5:180–187.

Perl TM . Prevention of Staphylococcus aureus infections among surgical patients: Beyond traditional perioperative prophylaxis. Surgery, 2003; 134,5 Suppl:S10–S17.

Gaynes R , Edwards JR . National Nosocomial Infections Surveillance System: Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis, 2005; 41:848–854.

Hidron AI , Edwards JR , Patel J et al. National Healthcare Safety Network Team; Participating National Healthcare Safety Network Facilities. NHSN annual update: Antimicrobial-resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol, 2008; 29:996–1011.

Weigelt JA , Lipsky BA , Tabak YP et al. Surgical site infections: Causative pathogens and associated outcomes. Am J Infect Control, 2010; 38:112–120.

Morange-Saussier V , Giraudeau B , van der Mee N et al. Nasal carriage of MRSA in vascular surgery. Ann Vasc Surg, 2006; 20:767–772.

Schelenz S , Tucker D , Georgeu C et al. Significant reduction of endemic MRSA acquisition and infection in cardiothoracic patients by means of an enhanced targeted infection control programme. J Hosp Infect, 2005; 60:104–110.

Jog S , Cunningham R , Cooper S et al. Impact of preoperative screening for MRSA by real-time PCR in patients undergoing cardiac surgery. J Hosp Infect, 2008; 69:124–130.

Trautmann M , Stecher J , Hemmer W et al. Intranasal mupirocin prophylaxis in elective surgery: A review of published studies. Chemotherapy, 2008; 54:9–16.

Van Rijen M , Bonten M , Wenzel R , Kluytmans J . Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev, 2008; 8,4:CD006216.

Harbath S , Fankhauser C , Schrenzel J et al. Universal screening for MRSA at hospital admission and nosocomial infection in surgical patients. JAMA, 2008; 299:1149–1157.

Awad SS , Palacio CH , Subramanian A et al. Implementation of a MRSA prevention bundle results in decreased MRSA surgical site infections. Am J Surg, 2009; 198:607–610.

Popovich KF , Weinstein RA , Hota B . Are community-associated MRSA strains replacing traditional nosocomial MRSA strains? Clin Infect Dis, 2008; 46:787–794.

Klevens RM , Morrison MA , Nadle J et al. Active Bacterial Core Surveillance (ABCs) MRSA Investigators. Invasive MRSA infections in the United States. JAMA, 2007; 298:1763–1771.

Manian FA , Griesnauer S . Community-associated MRSA is replacing traditional healthcare-associated strains in surgical site infections among inpatients. Clin Infect Dis, 2008; 47:434–435.

Kourbatova EV , Halvosa JS , King MD et al. Emergence of community-associated MRSA USA 300 clone as a cause of healthcare-associated infections among patients with prosthetic joint infections. Am J Infect Control, 2005; 33:385–391.

Naimi TS , leDell KH , Boxrud DJ et al. Epidemiology and clonality of community-acquired MRSA in Minnesota; 1996–1998. Clin Infect Dis, 2001; 33:990–996.

Frazee BW , Lynn J , Charlebois ED et al. High prevalence of MRSA in emergency department skin and soft tissue infections. Ann Emerg Med, 2005; 45:311–320.

Moran GJ , Krishnadasan A , Gorwitz RJ et al. EMERGEncy ID Net Study Group. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med, 2006; 355:666–674.

King MD , Humphrey BJ , Wang YF et al. Emergence of community-acquired MRSA USA 300 clone as the predominant cause of skin and soft tissue infections. Ann Intern Med, 2006; 144:309–317.

Edelsberg J , Taneja C , Zervos M et al. Trends in U.S. hospital admissions for skin and soft tissue infections. Emerg Infect Dis, 2009; 15:1516–1518.

Miller LG , Perdreau-Remington F , Rieg G et al. Necrotizing fasciitis caused by CA-MRSA in Los Angeles. N Engl J Med, 2005; 352:1445–1453.

Napolitano LM . Severe soft tissue infections. Infect Dis Clin North Am, 2009; 23:571–591.

Ruiz ME , Yohannes S , Wladyka CG . Pyomyositis caused by MRSA. N Engl J Med, 2005; 352:1488–1489.

Young LM , Price CS . Community-acquired MRSA emerging as an important cause of necrotizing fasciitis. Surg Infect, 2008; 9:469–474.

Wibbenmeyer LA , Kealey GP , Latenser BA et al. Emergence of the USA 300 strain of MRSA in a burn-trauma unit. J Burn Care Rehab, 2008; 29:790–797.

May AK , Stafford RE , Bulger EM et al. Therapeutic Agents Committee of the Surgical Infection Society. Surgical infection guidelines for the treatment of complicated skin and soft tissue infections. Surg Infect, 2009; 10:469–499.

Pepin J , Valiquette L , Alary ME et al. Clostridium difficile-associated diarrhea in a region of Québec from 1991 to 2003: A changing pattern of disease severity. CMAJ, 2004; 171:466–472.

Warny M , Pepin J , Fang A , Killgore G et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet, 2005; 366:1079–1084.

Labbe AC , Poirier L , MacCannell D et al. Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Antimicrob Agents Chemother, 2008; 52:3180–3187.

Zerey M , Paton BL , Lincourt AE et al. The burden of Clostridium difficile in surgical patients in the United States. Surg Infect, 2007; 8:557–566.

Carignan A , Allard C , Pepin J et al. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain. Clin Infect Dis, 2008; 46:1848–1843.

Sailhamer EA , Carson K , Chang Y et al. Fulminant Clostridium difficile colitis: Patterns of care and predictors of mortality. Arch Surg, 2009; 144:433–439.

Chan S , Kelly M , Helme S et al. Outcomes following colectomy for Clostridium difficile colitis. Int J Surg, 2008; 7:78–81.

Byrn JC , Maun DC , Gingold DS et al. Predictors of mortality after colectomy for fulminant Clostridium difficile colitis. Arch Surg, 2008; 143:150–154.

Navaneethan U , Vege SS , Chari ST , Baron TH . Minimally invasive techniques in pancreatic necrosis. Pancreas, 2009; 38:867–875.

Friedland S , Kaltenbach T , Sugimoto M , Soetikno R . Endoscopic necrosectomy of organized pancreatic necrosis: A currently practiced NOTES procedure. J Hepatobiliary Pancreat Surg, 2008; 16:266–269.

Seewald S , Ang TL , Teng KC , Soehendra N . EUS-guided drainage of pancreatic pseudocysts, abscesses and infected necrosis. Dig Endosc, 2009; 21,Suppl 1:S61–S65.

Babu BI , Siriwardena AK . Current status of minimally invasive necrosectomy for post-inflammatory pancreatic necrosis. HPB, 2009; 11:96–102.

Dellinger EP , Tellado J , Soto NE et al. Early antibiotic treatment for severe acute necrotizing pancreatitis: A randomized, double-blind, placebo-controlled study. Ann Surg, 2007; 245:674–683.

Nathens AB , Curtis JR , Beale RJ et al. Management of the critically ill patient with severe acute pancreatitis. Crit Care Med, 2004; 32:2524–2536.

Besselink MG , van Santvoort HC , Buskens E et al. Dutch Acute Pancreatitis Study Group. Probiotic prophylaxis in predicted severe acute pancreatitis: A randomised, double-blind, placebo-controlled trial. Lancet, 2008; 371:651–659.

Van Santvoort HC , Bollen TL , Besselink MG et al. Describing peripancreatic collections in severe acute pancreatitis using morphologic terms: An international interobserver agreement study. Pancreatology, 2008; 8:593–599.

Kollef MH , Napolitano LM , Solomkin JS et al. Healthcare-associated infection (HAI): A critical appraisal of the emerging threat. Proceedings of the HAI Summit. Clin Infect Dis, 2008; 47:S55–S99.

National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control, 2004; 32:470–485.

Edwards JR , Peterson KD , Andrus ML et al. NHSN Facilities. National Healthcare Safety Network (NHSN) Report, data summary for 2006, issued June 2007. Am J Infect Control, 2007; 35:290–301.

Edwards JR , Peterson KD , Andrus ML et al. National Healthcare Safety Network Facilities. National Healthcare Safety Network (NHSN) Report, data summary for 2006 through 2007, issued November 2008. Am J Infect Control, 2008; 36:609–626Erratum in: Am J Infect Control 2009;36:425.

Wip C , Napolitano L . Bundles to prevent ventilator-associated pneumonia: How valuable are they? Curr Opin Infect Dis, 2009; 22:159–166.

U.S. Centers for Disease Control and Prevention/National Nosocomial Infections Surveillance–January 1992–May 1999. Am J Infect Control, 1999; 27:520–532.

Fridkin S , Weibel SF , Weinstein RA . Magnitude and prevention of nosocomial infections in the intensive care unit. Infect Dis Clin North Am, 1997; 11:479–496.

Rolain JM , Francois P , Hernandez D et al. Genomic analysis of an emerging multiresistant Staphylococcus aureus strain rapidly spreading in cystic fibrosis patients revealed the presence of an antibiotic inducible bacteriophage. Biol Direct, 2009; 4:1.

Teixeira PJ , Seligman R , Hertz FT et al. Inadequate treatment of ventilator-associated pneumonia: Risk factors and impact on outcomes. J Hosp Infect, 2008; 65:361–367.

Rea-Neto A , Youssef NC , Tuche F et al. Diagnosis of ventilator-associated pneumonia: A systematic review of the literature. Crit Care, 2008; 12:R56.

Tejerina E , Esteban A , Fernandez-Segoviano P et al. Accuracy of clinical definitions of ventilator-associated pneumonia: Comparison with autopsy findings. J Crit Care, 2009 Jul 8[Epub ahead of print].

Klompas M . Does this patient have ventilator-associated pneumonia? JAMA, 2007; 297:1583–1593.

Luyt CE , Combes A , Reynaud C et al. Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med, 2008; 34:1434–1440.

Ramirez P , Garcia MA , Ferrer M et al. Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia. Eur Respir J, 2008; 31:356–362.

Linssen CF , Bekers O , Drent M , Jacobs JA . C-reactive protein and procalcitonin concentrations in BAL fluid as a predictor of ventilator-associated pneumonia. Ann Clin Biochem, 2008; 45:293–298.

Gibot S , Cravoisy A , Levy B et al. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med, 2004; 350:451–458.

Determann RM , Millo JL , Gibot S et al. Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia. Intensive Care Med, 2005; 31:1495–500.

Anand NJ , Zuick S , Klesney-Tait J , Kollef MH . Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. Chest, 2009; 135:641–647.

Oudhuis GJ , Beuving J , Bergmans D et al. Soluble triggering receptor expressed on myeloid cells-1 in bronchoalveolar lavage fluid is not predictive for ventilator-associated pneumonia. Intensive Care Med, 2009; 35:1265–1270.

Cobb JP , Moore EE , Hayden DL et al. Validation of the riboleukogram to detect ventilator-associated pneumonia after severe injury. Ann Surg, 2009 Aug 27[Epub ahead of print].

Napolitano LM , Brunsvold ME , Reddy RC , Hyzy RC . Community-acquired MRSA pneumonia and ARDS: 1-Year followup. Chest, 2009; 136:1407–1412.

Hidron AI , Low CE , Honig EG , Blumberg HM . Emergence of community-acquired MRSA strain USA300 as a cause of necrotizing community-onset pneumonia. Lancet Infect Dis, 2009; 9:384–392.

Kallen AJ , Brunkard J , Moore Z et al. Staphylococcus aureus community-acquired pneumonia during the 2006–2007 influenza season. Ann Emerg Med, 2009; 53:358–365.

Labandeira-Rey M , Couzon F , Boisset S et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science, 2007; 315:1130–1133.

Wenzel RP , Bearman G , Edmond MB . Community-acquired methicillin-resistant Staphylococcus aureus (MRSA): New issues for infection control. Int J Antimicrob Agents, 2007; 30:210–212.

Craven DE , Chroneou A , Zias N , Hjalmarson KI . Ventilator-associated tracheobronchitis: The impact of targeted antibiotic therapy on patient outcomes. Chest, 2009; 521–528.

Nseir S , Favory R , Jozefowica E et al. VAT Study Group. Antimicrobial treatment for ventilator-associated tracheobronchitis: A randomized, controlled, multicenter study. Crit Care, 2008; 12:R62–R68.

Nseir S , DiPompeo C , Soubrier S et al. Effect of ventilator-associated tracheobronchitis on outcome in patients without chronic respiratory failure: A case-control study. Crit Care, 2005; 9:R238–R245.

Palmer LB , Smaldone GC , Chen JJ et al. Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Crit Care Med, 2008; 36:2008–2013.

Berenholtz SM , Pronovost PJ , Lipsett PA et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med, 2004; 32:2014–2020.

Pronovost P , Needham D , Berenholtz S et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med, 2006; 355:2725–2732.

Popovich KJ , Weinstein RA , Hota B . Are community-associated MRSA strains replacing traditional nosocomial MRSA strains? Clin Infect Dis, 2008; 46:787–794.

Earley AS , Pryor JP , Kim PK et al. An acute care surgery model improves outcomes in patients with appendicitis. Ann Surg, 2006; 244:498–504.

von Ridenauer WB , Knipp B , Mallat A et al. Critical care profile of non-trauma emergency general surgery. Critical Care Med, 2007; 35,12 Suppl:A70.

General Surgery News, 2008 May 28 35,5.

John Marshall MD . Coming of age. Surg Infect, 2008; 9:18–20.

Solomkin JS , Mazuski JE , Bradley JS et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect, 2010; 11:79–109.